BREVIVE

Welcome to the Brand page for “BREVIVE”, which is offered here for Pharmaceuticals for the treatment of nose and sinus and respiratory-related conditions and symptoms;medical devices consisting of artificial materials for the treatment of nose and sinus and respiratory-related conditions and symptoms, implants comprised of drug-eluting stents; drug delivery systems; surgical devices and instruments for the treatment of nose and sinus and respiratory-related conditions and symptoms;.

Its status is currently believed to be active. Its class is unavailable. “BREVIVE” is believed to be currently owned by “Intersect ENT Inc.”